Teva earnings preview: Opioid suits are 'key' - MarketWatch
Israel's Teva gives upbeat outlook as restructuring proceeds | The Seattle Times
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters")
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
The Laundry List of Reasons Behind Teva Pharmaceutical Industries' 48% Tumble in 2017 | The Motley Fool
Teva to cut 14,000 jobs | Business | Chemistry World
Teva sells remaining women's health assets
Israeli drugmaker Teva, with location in Overland Park, to cut quarter of global work force
Teva Lands A CEO: Can Schultz Replicate Lundbeck Success? :: Scrip
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | Business
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Teva Pharm expects to start paying US opioid settlement in 2023 - CNA
Teva cut to Sell at UBS citing uncertainty over leadership transition (NYSE: TEVA) | Seeking Alpha
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva to shutter Israeli R&D site in company reorganization | Fierce Biotech
Teva scales down Japanese operations - Globes
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Israeli drugmaker Teva to cut quarter of global work force | The Seattle Times
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva наконец-то выбрала нового исполнительного директора | МОСМЕДПРЕПАРАТЫ
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
